Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association
Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association
复制标题
DOI：
10.1093/europace/euu300
复制
发表时间：
2015-01-01
期刊：
影响因子：
6.1
通讯作者：
Kuck, Karl-Heinz
中科院分区：
文献类型：
--
作者：
Raatikainen, M. J. Pekka;Arnar, David O.;Kuck, Karl-Heinz
目的：欧洲心脏病学会（ESC）成员国在使用侵入性电生理治疗方面存在很大差异。本分析的目的是提供全面的信息，心脏植入式电子设备（CIED）和导管消融治疗的趋势，在ESC国家在过去的five-years.Methods欧洲心律协会（EHRA）收集数据，自2008年以来CIED和导管消融治疗。去年，56个ESC成员国中有49个为EHRA白色手册提供了数据。本分析基于EHRA白色手册的当前版本和以前版本。每个ESC国家和五个地理ESC regions.Results在2013年，每百万人口的电生理手术率最高的是西欧，其次是南部和北方欧洲国家。东欧和非欧洲ESC国家的CIED植入率和导管消融率分别最低。然而，在一些东欧国家相对较低的国内生产总值的程序率超过了一些富裕的西方国家，这表明经济资源不是唯一的驱动程序利用心律失常therapy.Conclusion这些统计数据表明，尽管有显着的改善，仍然有相当大的异质性，在整个ESC区域心律失常治疗的可用性。希望这些数据将有助于确定需要改进的领域，并指导心律失常管理的未来活动。
Aims There has been large variations in the use of invasive electrophysiological therapies in the member countries of the European Society of Cardiology (ESC). The aim of this analysis was to provide comprehensive information on cardiac implantable electronic device (CIED) and catheter ablation therapy trends in the ESC countries over the last five years.Methods The European Heart Rhythm Association (EHRA) has collected data on CIED and catheter ablation therapy since 2008. Last year 49 of the 56 ESC member countries provided data for the EHRA White Book. This analysis is based on the current and previous editions of the EHRA White Book. Data on procedure rates together with information on economic aspects, local reimbursement systems and training activities are presented for each ESC country and the five geographical ESC regions.Results In 2013, the electrophysiological procedure rates per million population were highest in Western Europe followed by the Southern and Northern European countries. The CIED implantation and catheter ablation rate was lowest in the Eastern European and in the non-European ESC countries, respectively. However, in some Eastern European countries with relative low gross domestic product procedure rates exceeded those of some wealthier Western countries, suggesting that economic resources are not the only driver for utilization of arrhythmia therapies.Conclusion These statistics indicate that despite significant improvements, there still is considerable heterogeneity in the availability of arrhythmia therapies across the ESC area. Hopefully, these data will help identify areas for improvement and guide future activities in cardiac arrhythmia management.